SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Wickman Magnus C.)
 

Sökning: WFRF:(Wickman Magnus C.) > The complex pathoph...

  • Bjermer, LeifLund University,Lunds universitet,Skåne University Hospital (författare)

The complex pathophysiology of allergic rhinitis : Scientific rationale for the development of an alternative treatment option

  • Artikel/kapitelEngelska2019

Förlag, utgivningsår, omfång ...

  • 2019-04-16
  • Springer Science and Business Media LLC,2019

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:4c7c268a-c04e-42df-9c4a-e5e9e887ec7a
  • https://lup.lub.lu.se/record/4c7c268a-c04e-42df-9c4a-e5e9e887ec7aURI
  • https://doi.org/10.1186/s13223-018-0314-1DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:140733415URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:for swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Allergic rhinitis (AR) poses a global health problem and can be challenging to treat. Many of the current symptomatic treatments for AR have been available for decades, yet there has been little improvement in patient quality of life or symptom burden over the years. In this review, we ask why this might be and explore the pathophysiological gaps that exist within the various AR treatment classes. We focus on the benefits and drawbacks of different treatment options and delivery routes for AR treatments and consider how, given what is known about AR pathophysiology and symptomatology, patients may be offered more effective treatment options for rapid, effective, and sustained AR control. In particular, we consider how a new AR preparation, MP-AzeFlu (Dymista ® , Meda, Sweden), comprising a formulation of an intranasal antihistamine (azelastine hydrochloride), an intranasal corticosteroid (fluticasone propionate), and excipients delivered in a single spray, may offer benefits over and above single and multiple AR therapy options. We review the evidence in support of this treatment across the spectrum of AR disease. The concept of AR control is also reviewed within the context of new European Union and Contre les Maladies Chroniques pour un VIeillissement Actif-Allergic Rhinitis and its Impact on Asthma initiatives.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Westman, MaritKarolinska Institutet,Karolinska Institute,Karolinska University Hospital (författare)
  • Holmström, MatsKarolinska Institutet,Karolinska Institute (författare)
  • Wickman, Magnus C.Karolinska Institute (författare)
  • Lunds universitetSkåne University Hospital (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Allergy, Asthma and Clinical Immunology: Springer Science and Business Media LLC15, s. 24-1710-1492
  • Ingår i:Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology: Springer Science and Business Media LLC15, s. 24-1710-1484

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy